Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A small deletion in SERPINC1 causes type I antithrombin deficiency by promoting endoplasmic reticulum stress.
|
27708219 |
2016 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
SERPINC1 was sequenced in 214 cases with a positive test for antithrombin deficiency, including 67 with no deficiency in the sample delivered to our laboratory.
|
27098529 |
2016 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
|
3116713 |
1987 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Therefore, this is the first mutation affecting a regulatory region of the SERPINC1 gene associated with antithrombin deficiency.
|
22234719 |
2012 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Identification of mutations in the SERPINC1 gene has revealed different mechanisms responsible for antithrombin deficiency.
|
20435622 |
2010 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel splice-site mutation c.42-2A>T (IVS1-2A>T) of SERPINC1 in a Korean family with inherited antithrombin deficiency.
|
21885952 |
2011 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We report 22 novel antithrombin gene (SERPINC1) mutations associated with antithrombin deficiency in 17 French and five German families.
|
16705712 |
2006 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
These results are consistent with previously published data suggesting that mutation of the antithrombin III structural gene is the cause of inherited antithrombin III deficiency in some families.
|
3162535 |
1988 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This study demonstrates that the search for large gene rearrangements in SERPINC1 can be a useful diagnostic approach, particularly in patients with type I antithrombin deficiency without mutations in SERPINC1.
|
25083771 |
2015 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Coagulation tests revealed that the patient presented type I antithrombin deficiency combined with decreased protein C activity resulting from a small insertion mutation c.848_849insGATGT in SERPINC1 and a short deletion variant c.572_574delAGA in PROC.
|
28861852 |
2018 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
|
24196373 |
2014 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
This thrombus formation was attributed to antithrombin deficiency caused by a novel SERPINCI gene mutation (AT III Akita, M352R).
|
15338392 |
2004 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Current evidence shows that some SERPINC1 mutations responsible for antithrombin deficiency often present a slightly decreased or normal activity and therefore could not be detected by functional tests.
|
25298121 |
2015 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Two SERPINC1 mutations causing type II antithrombin deficiency, Arg79Cys and Ser158Pro, were prevalent in the population group.
|
24162787 |
2014 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Inherited quantitative (type I) or qualitative (type II) antithrombin deficiency (ATD) due to mutations in the SERPINC1 gene is a well-known risk factor for venous thromboembolism.
|
28300866 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The analysis of latent antithrombin in 141 unrelated patients with antithrombin deficiency carrying 89 different SERPINC1 mutations identified four cases with higher levels than that of controls: p.Pro439Thr, p.Pro461Ser, p.Met283Val, and p.His401Tyr, the last also with circulating polymers.
|
28229161 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
SERPINC1 gene mutations in antithrombin deficiency.
|
28317092 |
2017 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In one of these families antithrombin III deficiency is caused by hemizygosity of the ATIII locus.
|
3663935 |
1987 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Most cases with antithrombin deficiency carried genetic defects affecting exons or flanking regions of SERPINC1.We aimed to identify regulatory mutations inSERPINC1 through sequencing the promoter, intron 1 and 2 of this gene in 23 patients with antithrombin deficiency but without known genetic defects.
|
27003919 |
2016 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A series of 10 Polish patients with thromboembolic events and antithrombin deficiency: two new c.1154-1 G>C and c.1219-534 A>G SERPINC1 gene splicing mutations.
|
31157679 |
2019 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.
|
19760264 |
2010 |
Antithrombin III Deficiency
|
1.000 |
Biomarker
|
disease |
BEFREE |
Up to 80% of patients with antithrombin deficiency have SERPINC1 gene defects, mostly (90% of the 315 gene defects described so far) point mutations or small deletions or insertions affecting the 7 exons or flanking regions.
|
30005274 |
2018 |
Antithrombin III Deficiency
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
The level of antithrombin III was often decreased in patients with preeclampsia - (32.4%), then in the other patients - (17.2%) (P=0.04), but no patient was diagnosed with antithrombin III deficiency (diagnosis: level<60%).
|
28792912 |
2018 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Molecular basis of SERPINC1 mutations in Japanese patients with antithrombin deficiency.
|
31030036 |
2019 |
Antithrombin III Deficiency
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Patients/methods We studied 30 patients with antithrombin deficiency but no defects in the gene encoding this key anticoagulant (SERPINC1).
|
27214821 |
2016 |